Court restricts abortion access across US by blocking mailing of mifepristone
Summary
A federal appeals court has blocked the mailing of mifepristone, a common abortion pill, requiring it to be given only in person at clinics. This decision limits access to abortion and miscarriage care across the United States, especially affecting people in rural and low-income communities.Key Facts
- The 5th U.S. Circuit Court of Appeals in New Orleans issued the ruling.
- The court stated that allowing mail distribution of mifepristone cancels Louisiana’s ban on medical abortions.
- The ruling requires mifepristone to be distributed only in clinics, not by mail.
- Since the Supreme Court overturned Roe v. Wade in 2022, mailing abortion pills has been a common way to access abortions in states with bans.
- The American Civil Liberties Union (ACLU) says this decision will reduce abortion and miscarriage care access nationwide.
- The ruling will mostly affect rural people, those with low incomes, people with disabilities, survivors of abuse, and communities of color.
- Mifepristone is one of the most common medicines used to end pregnancies early.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.